Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR - ICR / Cancer Research Society Partnership - Research Grants

Université de Montréal

$59,340.00

Tumor-innervating PDL1+ neurons block cancer immunosurveillance

EF 2020-21

Résumé
Itch is a common feature of various cancers, while cancer cells actively secrete factors promoting neuronal infiltration of tumors. Experimentally stopping the electrical signals of tumor-infiltrating neurons help decrease tumor growth, but the specific means by which neurons regulate cancer cells' survival is yet to be uncovered. Given that we discovered that cancer cells drive major changes in the gene expression profiles of tumor-infiltrating noxious detecting neurons, we hypothesize that cancer cells exploit nociceptors interplay with the immune system to sustain their growth and survival. To investigate this, we aim to study: 1) characterize the sensory function of nociceptor-specific PD-L1 knockout mice. 2) analyze if PD-L1 knockout neurons prevent CD8 T cells exhaustion. 3) assess whether nociceptor?pdl1 preserve anti-tumor immunity. 4) test whether malignant cell sensitivity to therapy is increased in nociceptor?pdl1 mice. Studying the biology of cancer, by simultaneously embracing the disease’s nervous and immune aspects, as well as their reciprocal interplay, will likely lead to the discovery of unexpected biology and novel therapeutic avenues. As such, this proposal represents the first attempt to amplify the immune system’s capacity to fight cancer cells by harnessing the nervous and immune system’s interplay.
Programme
CIHR - ICR / Cancer Research Society Partnership - Research Grants
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
453488
Name
Talbot Sébastien
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Cancer Research Society Inc.; Cancer Research Society Inc.
Instname2
Cancer Research
Prcname2
Special Cases
Projecttitle
Tumor-innervating PDL1+ neurons block cancer immunosurveillance
Programtype2
Operating Grants
Orgnameinp2
Université de Montréal
Cihramount2
$59,340
Cihrequipment2
$0
Programname2
CIHR - ICR / Cancer Research Society Partnership - Research Grants
Keyworddelim
Approaches; Genomics; Imaging Technologies; Tumour Progression And Metastasis
Abstract
Itch is a common feature of various cancers, while cancer cells actively secrete factors promoting neuronal infiltration of tumors. Experimentally stopping the electrical signals of tumor-infiltrating neurons help decrease tumor growth, but the specific means by which neurons regulate cancer cells' survival is yet to be uncovered. Given that we discovered that cancer cells drive major changes in the gene expression profiles of tumor-infiltrating noxious detecting neurons, we hypothesize that cancer cells exploit nociceptors interplay with the immune system to sustain their growth and survival. To investigate this, we aim to study: 1) characterize the sensory function of nociceptor-specific PD-L1 knockout mice. 2) analyze if PD-L1 knockout neurons prevent CD8 T cells exhaustion. 3) assess whether nociceptor?pdl1 preserve anti-tumor immunity. 4) test whether malignant cell sensitivity to therapy is increased in nociceptor?pdl1 mice. Studying the biology of cancer, by simultaneously embracing the disease’s nervous and immune aspects, as well as their reciprocal interplay, will likely lead to the discovery of unexpected biology and novel therapeutic avenues. As such, this proposal represents the first attempt to amplify the immune system’s capacity to fight cancer cells by harnessing the nervous and immune system’s interplay.
Competitiondate
202103
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Talbot, Sébastien
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Cancer Research~ $59,340~ $0~